Nottingham Clinical Trials Unit
The University of Nottingham
University of Nottingham




Promoting Independence in Dementia (PRIDE): A Feasibility Randomised Controlled Trial

Chief Investigator: Martin Orrell, University of Nottingham

 Dementia is a national priority in the UK. Over 800,000 older people in the UK have dementia which can lead to social exclusion, loss of identity and loss of independence due to deterioration in cognition and activities of daily living, the double stigma of age and dementia and the reduced capacity for social participation.

The PRIDE Programme aims to promote independence for people with dementia by investigating how social and lifestyle changes may reduce risk of dementia, and understanding the social impact of dementia, in order to develop and evaluate an effective social intervention to enhance independence and quality of life for people with mild dementia and the friends and family that support them. The present study is a feasibility randomised controlled trial (RCT) of the PRIDE social intervention for living well with dementia to determine the feasibility and inform the design of a large multi-centre randomised control trial.

The trial recruited in 6 sites and the target was to recruit 75-80 participants by the end of June 2019.  The trial recruited 92 participants and is now closed to recruitment and in follow up phase.

Contact: Aisha Shafayat                  Email:             

Funding: ESRC and NIHR programme

Status: Follow-up



 STAndardised DIagnostic Assessment for children and adolescents with emotional difficulties (STADIA): a multi-centre randomised controlled trial

Chief Investigator: Kapil Sayal, University of Nottingham

This research focuses on children and adolescents with significant levels of emotional difficulties (such as anxiety or depression) who have been referred to Child and Adolescent Mental Health Services (CAMHS) for specialist help. The trial will investigate whether the use of a standardised diagnostic assessment (SDA) tool helps with the assessment and diagnosis process in CAMHS. The effectiveness and cost-effective of this approach will be evaluated. Specifically, the research will explore whether the SDA tool makes a difference to rates of diagnosis and whether this better helps children and their family access appropriate treatment. Follow-up will continue for 12 months to assess the impact on the children’s emotional difficulties, day-to-day functioning and quality of life.

Recruitment commenced in August 2019 and ended in Oct 2021.

Contact:  Laura Wyatt             Email:                    

Funding: NIHR HTA programme

Status: Follow up


Nottingham Clinical Trials Unit

General enquiries
Telephone: +44 (0)115 8231600